跳至主要内容
临床试验/NCT01737788
NCT01737788终止不适用

Randomised Trial of Cervical Cerclage With and Without Occlusion for the Prevention of Preterm Birth in Women Suspected for Cervical Insufficiency

Niels Jørgen Secher23 个研究点 分布在 9 个国家目标入组 309 人开始时间: 2006年8月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
309
试验地点
23
主要终点
Take-home baby rate

研究概览

简要总结

The aim of this study was to evaluate the effect of cervical occlusion versus no cervical occlusion in women with cervical cerclages.

详细描述

Cervical weakness and ascending infection have long been considered important causes of preterm birth. Cervical occlusion could theoretically be used for the treatment of cervical weakness and to protect the cervix against infection. A cervical cerclage could be placed to increase the cervical resistance, and occlusion of the external os could be performed to retain the cervical mucus plug thereby preventing infection. The aim of this multicentre, stratified, randomised controlled trial was to evaluate the effect of cervical occlusion versus no cervical occlusion in women with prophylactic and therapeutic cervical cerclages.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • The physician in charge considered that a cerclage was indicated.
  • Gestational age between 12 and 27 completed weeks.
  • Previous late mid-trimester miscarriage, or spontaneous preterm labour and delivery before 28 weeks with or without previous cerclages.
  • Previous cerclage because of short cervix.
  • Confirmed gestational age defined as gestational age estimated by ultrasound at less than or equal to 22+0 weeks, and/or certain last menstrual period.
  • Vaginal infection treated before cerclage.
  • Ability to read and understand the relevant national language.
  • Consent obtained in accordance with specifications of the local research ethics committee.
  • 18 years or more of age and legally competent.

排除标准

  • Demonstrated cervical infection.
  • Obstetrical complications in the current pregnancy.
  • Multiple pregnancies.
  • History of a significant abruptio placenta in a previous pregnancy.

结局指标

主要结局

Take-home baby rate

时间窗: Neonates will be followed for the duration of stay in the neonatal intensive care unit, an expected average of 28 days with a minimum of 0 days up to a maximum of 98 days.

Take-home baby rate was defined as the proportion of living babies discharged from the hospital of all singleton pregnancies.

次要结局

  • Gestational age at birth(At birth)

研究者

发起方
Niels Jørgen Secher
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Niels Jørgen Secher

Professor

Hvidovre University Hospital

研究点 (23)

Loading locations...

相似试验

已完成
不适用
Prevention of preterm birthTopic: Reproductive HealthSubtopic: Reproductive Health & Childbirth (all Subtopics)Disease: Reproductive Health & ChildbirthPregnancy and ChildbirthPreterm birth
ISRCTN11186205niversity of Liverpool (UK)39
招募中
不适用
Prophylactic Cervical Cerclage in Twin Pregnancies With Non-shortened CervixPreterm BirthTwin Pregnancy, Antepartum Condition or ComplicationCervical Cerclage
NCT05334264Zagazig University170
已完成
不适用
Randomised trial of cervical cerclage in women with a short cervix identified by routine sonography at 23 weeks of pregnancyPregnancy and childbirth: PregnancyPregnancy and ChildbirthPregnancy
ISRCTN61066532HS R&D Regional Programme Register - Department of Health (UK)250
Unknown
3 期
A randomised controlled trial comparing cervical medial branch blocks by ultrasound-guided with combined bupivacaine and steroid versus bupivacaine alone for chronic cervical facet joint paiChronic cervical facet joint pain patientsCervical medial branch blocksChronic cervical facet joint painUltrasond guidance
TCTR20210301008Mahidol University54
已完成
不适用
Validation of efficacy of cervical cerclage in patients with short cervical lengthPregnant women with subclinical infection and cervical length &amp#6160325 mm as diagnosed by transvaginal ultrasonography in a maternity health examination conducted during the second trimester of pregnancy (between week 16 day 0 and week 26 day 6 of gestation)
JPRN-UMIN000001870Japan Organization of Prevention of Preterm Delivery300